Abstract:Background Malignant pleural effusion (MPE) is a common complication in patients with advanced lung cancer that can severely compromise the quality of life and limit life expectancy. Randomized controlled trials (RCTs) have shown that Chinese herbal injections (CHIs) may be beneficial in improving quality of life. This network meta-analysis (NMA) aims to explore several CHIs used for lung cancer patients with MPE. Methods Seven databases were systematically searched for eligible RCTs from inception to November 2021. The primary outcome was the clinical effective rate. Secondary outcomes were the improvement rate of Karnofsky performance status (KPS) score and incidence of adverse events (AEs). The Cochrane risk of bias 2 tool was used to assess the quality of included studies. Data analysis was performed using STATA 16.0 and R software 4.1.0. Both pairwise meta-analysis and Bayesian NMA were conducted. Competing interventions were ranked using the surface under the cumulative ranking (SUCRA) probabilities. Evidence grading was evaluated using the Confidence in Network Meta-Analysis online software ( https://cinema.ispm.unibe.ch/ ). Results A total of 44 studies involving 2,573 patients were included. The combined Huachansu injection (HCS) with intrapleural cisplatin (cis-diamminedichloro-platinum, DDP) had the highest probability of improving the clinical effective rate (SUCRA, 84.33%). The Kangai injection (KA) combined with DDP had the most improvement rate of KPS score (SUCRA, 80.82%), while the Fufangkushen injection (FFKS) alone was more likely to reduce AEs including gastrointestinal reactions (SUCRA, 89.92%), leukopenia (SUCRA, 91.85%), and chest pain (SUCRA, 98.17%). FFKS combined with DDP ranked the best in reducing the incidence of fever (SUCRA, 75.45%). Conclusions Our NMA showed that CHIs alone or combined with DDP could improve clinical effectiveness and quality of life and reduce AEs, compared to DDP alone. HSC and KA, combined with DDP, may be the most effective considering clinical effective rate and improvement of KPS score, respectively. FFKS, either used alone or in combination therapy with DDP, may be the best in reducing AEs. However, high-quality RCTs with larger sample sizes are needed to further support the evidence. Systematic review registration PROSPERO https://www.crd.york.ac.uk/prospero/ , identifier CRD42021285275.

Therapeutic Efficacy and Safety of Pseudomonas aeruginosa Preparations for Malignant Pleural Effusion:A Meta-analysis

Pseudomonas aeruginosainfections in patients with malignant ascites and drug resistance

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant <i>Pseudomonas</i> aeruginosa Infection

Effect of Hyperthermic Intrathoracic Chemotherapy (hithoc) on the Malignant Pleural Effusion A Systematic Review and Meta-Analysis

Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis

A Meta-analysis of the clinical efficacy and safety of elemene combined cis-platinum pleural perfusion for the treatment of malignant pleural effusion

Investigation on the efficiency of Brucea javanica oil emulsion injection with chemotherapy for treating malignant pleural effusion: A meta-analysis of randomized controlled trials.

Neoadjuvant Pseudomonas Aeruginosa Mannose-Sensitive Hemagglutinin (PA-MSHA) and Chemotherapy Versus Placebo Plus Chemotherapy in Patients with HER2-negative Breast Cancer: a Randomized, Controlled, Double-Blind Trial

Efficacy and Safety of Inhaled Amphotericin B in Prophylaxis of Invasive Pulmonary Aspergillosis:A Meta-analysis

Evaluation of Efficacy and Safety for Recombinant Human Adenovirus-P53 in the Control of the Malignant Pleural Effusions Via Thoracic Perfusion

Clinical observation of intra-cavity rAd-p53 infusion in 34 patients with malignant pleuroperitoneal effusion

Clinical Characteristics and Prognostic Factors in Breast Cancer with Malignant Pleural Effusion

Effects of intrapleural therapy on 96 patients with malignant pleural effusion

Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world

Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials

Diagnostic and Prognostic Significance of Lysophosphatidic Acid in Malignant Pleural Effusions.

Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials

Feasibility, Efficacy and Safety—A Systematic Review and Meta-Analysis

A clinical analysis of Pseudomonas aeruginosa pulmonary infection in respiratory intensive care unit

Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials

Pseudomonas Aeruginosa Preparation Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Randomized, Multicenter, Double-Blind Phase Iii Study